GL1X · GenesisL1 explorer

MolNFT v1 · #50421 · protein

P94L actinorhodin ketordeuctase mutant, with NADPH and inhibitor emodin

2RHR · Actinorhodin polyketide ketoreductase: “P94L actinorhodin ketordeuctase mutant, with NADPH and inhibitor emodin”. X-ray diffraction, 2 ligands (NDP, EMO), 4 pockets (best druggability 0.76). MolNFT v1 #50421 on GenesisL1: 3D…

PDB
2RHR
Type
protein
Length
512 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Actinorhodin polyketide ketoreductase
EC
1.3.1.-
UniProt
P16544
Ligands
NDP, EMO
Pockets
4 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 48% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BActinorhodin polyketide ketoreductase (EC 1.3.1.-)protein25646% helix, 16% strandP16544
AActinorhodin polyketide ketoreductase (EC 1.3.1.-)protein25649% helix, 16% strandP16544

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · 2 copies · chains B, A
  • EMO · 3-methyl-1,6,8-trihydroxyanthraquinone · ligand · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17340.760.8161NDP, EMO
25860.740.8156NDP
31310.450.7730empty
4740.370.7812empty

Interfaces

1 interface between chains.

  • B–A · 1651 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 2RHR · P94L actinorhodin ketordeuctase mutant, with NADPH and Inhibitor Emodin · the same entry in another collection · chain B against B, TM-score 1.00
  • P16544 · AlphaFold monomer V2.0 prediction for putative ketoacyl reductase (P16544) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.